In the pharmaceutical industry, where patient safety is paramount, many facilities still rely on legacy systems and traditional weir-style sanitary diaphragm valves. These technologies, developed decades ago, were not designed to meet today’s rigorous standards for cleaning validation, contamination control, and long-term maintainability. This article examines the regulatory and cultural barriers to change, the engineering case for radial diaphragm valve technology, and what a move away from weir-style valves means for cleaning validation, maintenance burden, and total cost of ownership.

Download the full article (PDF)

Published in GMP Review, Vol. 23 No. 1, January 2026. By John Swibes and David Grote.